At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Reduction of Antibiotic Therapy by Biomakers in Patients With CAP Episodes (REDUCE Study)
In Brief
A clinical study evaluating Discontinuation of treatment according to CRP levels, Discontinuation of treatment according to PCT levels, and 1 other intervention for Community Acquired Pneumonia. Completed, enrolled 468 participants across 3 sites.
Detailed Summary
The purpose of this study is to evaluate two different treatment strategies in patients admitted to hospital with Community Acquired Pneumonia. The investigators hypothesize treatment according to both procalcitonin (PCT) and C-reactive protein (CRP) will be effective in reducing the length of antibiotic treatment.
Study Details
Timeline
Interventions
The cutoff point is a CRP below 100 mg/L and a reduction to 50% of the initial value.
The cutoff point is a PCT below 0.25 mcg/L or a reduction to 10% of the initial value.
Often a 7 days course of antibiotics, treatment may be extended if the attending physician deems it necessary.